HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.

AbstractIMPORTANCE:
Little is known about survival after a diagnosis of a second or higher-order (multiple) primary melanoma, and no study has explored survival in a population-based sample that included patients with single primary melanomas (SPMs) and multiple primary melanomas (MPMs) of any stage. Because people with a first primary melanoma are known to have an increased risk of being diagnosed with another, evidence for prognosis is needed.
OBJECTIVE:
To determine whether survival after diagnosis was better in patients with MPMs than with SPMs, as suggested in a recent study. DESIGN Survival analysis with median follow-up of 7.6 (range, 0.4-10.6) years.
SETTING:
The Genes, Environment, and Melanoma Study enrolled incident cases of melanoma from population-based cancer registries in Australia, Canada, Italy, and the United States. Multiple primary melanomas were ascertained during a longer period than SPM.
PARTICIPANTS:
Two thousand three hundred seventy-two patients with SPM and 1206 with MPM.
EXPOSURE:
Diagnosis with melanoma.
MAIN OUTCOMES AND MEASURES:
Melanoma-specific fatality hazard ratios (HR) and 95% confidence intervals associated with clinical and pathological characteristics of SPM, MPM, and both in Cox proportional hazards regression models.
RESULTS:
Melanoma thickness was the main determinant of fatality (HR for >4 mm, 7.68 [95% CI, 4.46-13.23]); other independent predictors were ulceration, mitoses, and scalp location. After adjustment for these other predictors, we found little difference in fatality between MPM and SPM (HR for MPM relative to SPM, 1.24 [95% CI, 0.91-1.69; P = .18]). Thicker SPM, however, had higher fatality (HR for >4 mm, 13.56 [95% CI, 6.47-28.40]) than thicker MPM (2.93 [1.17-7.30]).
CONCLUSIONS AND RELEVANCE:
Although overall fatalities due to SPM and MPM were similar, relative fatality for thicker SPM was greater than that for thicker MPM. This finding may offer support for a difference in outcome between patients with SPM and MPM related to factors other than closer surveillance and earlier diagnosis. The better outcomes are worth further exploration.
AuthorsAnne Kricker, Bruce K Armstrong, Chris Goumas, Nancy E Thomas, Lynn From, Klaus Busam, Peter A Kanetsky, Richard P Gallagher, Loraine D Marrett, Pamela A Groben, Stephen B Gruber, Hoda Anton-Culver, Stefano Rosso, Terence Dwyer, Marianne Berwick,
JournalJAMA dermatology (JAMA Dermatol) Vol. 149 Issue 8 Pg. 921-7 (Aug 2013) ISSN: 2168-6084 [Electronic] United States
PMID23784017 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Melanoma (pathology)
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Multiple Primary (pathology)
  • Prognosis
  • Proportional Hazards Models
  • Registries
  • Skin Neoplasms (pathology)
  • Survival Analysis
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: